What about beta-blockers in the new glucose-insulin-potassium (GIK) era?
Bagger
J P
JP
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000628:therapy*; D006801:Humans; D007328:Insulin / Q000097:blood*; D009203:Myocardial Infarction / Q000628:therapy; D010101:Oxygen Consumption / Q000187:drug effects; D011188:Potassium / Q000097:blood*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007328:Insulin; D011188:Potassium